INS and type 2 diabetes mellitus: An RCT involving 72 insulin-treated participants with type 2 diabetes did report a reduction in hypoglycaemic events (<3.9 mmol/l) in hospital during CGM use compared with POC-BG monitoring (0.67 vs 1.69 events/participant, p=0.024) [65].